![]() |
||||
|
||||
|
|
||||
R: hormone replacement and s/p tah bsoFrom: Roberto Pasqualetti (robipas@freesurf.ch)Wed Oct 27 02:39:57 1999
-----Messaggio originale----- Da: Jomyrwhipt@aol.com <Jomyrwhipt@aol.com> A: Multiple recipients of list OB-GYN-L <ob-gyn-l@talk.obgyn.net> Data: mercoledì 27 ottobre 1999 1.33 Oggetto: hormone replacement and s/p tah bso
>I was just precepting a Family Practice Resident and the woman presented
> Progestins seems to have a inibitory effect on the breast cellular growth, but their role in decreasing the incidence of breast cancer has not been proved. I would use them anyway in patients c/o mastodinia under E2 only HRT. However, consider the negative influence that some progestins (es. norethisteron) have on the blood lipids.
>2. Is replacement of progesterone in a woman without a uterus necessary
Again nothing really proved, but prof. Huber in Wien is a strong suppoter of
the use of progestins in different settings: mastodinia, migraine, as
immunostimulants and something else I don't remember now.
>
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Mon Nov 2 05:32:36 2009 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.